Anthem and Cigna, which announced a $54 billion merger on Friday morning, probably won’t be able to consummate their deal for at least a year. Regulators are beginning to closely scrutinize the two […]
https://www.pharmalive.com/wp-content/uploads/2015/07/ANTM_CI5.png356851Forbes Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngForbes Health2015-07-24 13:30:002015-08-07 22:59:50Wall Street Hates The Anthem-Cigna Deal: The Two Companies Have Already Lost $3B In Value